Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 1998

Primary Completion Date

June 30, 2003

Conditions
Unspecified Childhood Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

filgrastim

DRUG

cyclophosphamide

DRUG

tirapazamine

Trial Locations (28)

13210

State University of New York - Upstate Medical University, Syracuse

21287

Johns Hopkins Oncology Center, Baltimore

27710

Duke Comprehensive Cancer Center, Durham

30322

Emory University Hospital - Atlanta, Atlanta

33136

Sylvester Cancer Center, University of Miami, Miami

35294

University of Alabama Comprehensive Cancer Center, Birmingham

48201

Children's Hospital of Michigan, Detroit

53226

Midwest Children's Cancer Center, Milwaukee

60614

Children's Memorial Hospital, Chicago, Chicago

63104

Cardinal Glennon Children's Hospital, St Louis

63110

Washington University School of Medicine, St Louis

72205

University of Arkansas for Medical Sciences, Little Rock

76104

Cook Children's Medical Center - Fort Worth, Fort Worth

77030

Baylor College of Medicine, Houston

78284

University of Texas Health Science Center at San Antonio, San Antonio

94304

Lucile Packard Children's Hospital at Stanford, Palo Alto

92093-0658

University of California San Diego Cancer Center, La Jolla

66160-7357

University of Kansas Medical Center, Kansas City

02111

Floating Hospital for Children, Boston

02115

Dana-Farber Cancer Institute, Boston

39216-4505

University of Mississippi Medical Center, Jackson

07601

Hackensack University Medical Center, Hackensack

14263-0001

Roswell Park Cancer Institute, Buffalo

38105-2794

Saint Jude Children's Research Hospital, Memphis

75235-9154

Simmons Cancer Center - Dallas, Dallas

M5G 1X8

Hospital for Sick Children, Toronto

H3H 1P3

Montreal Children's Hospital, Montreal

H3T 1C5

Hopital Sainte Justine, Montreal

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00003288 - Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors | Biotech Hunter | Biotech Hunter